Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Improving Affordability in Cancer Care for Resource-Limited Settings: Highlights From JCO Global Oncology.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 11, 2026
Multikinase inhibitors in refractory metastatic colorectal cancer: an optimal sequence?
Journal: Clinical advances in hematology & oncology : H&O
Published: February 20, 2026
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer.
Journal: Journal of gastroenterology
Published: January 30, 2026
Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysis.
Journal: NPJ precision oncology
Published: December 11, 2025
Successful Management of BRAF V600E-Mutated Metastatic Colorectal Cancer With Liver Dysfunction Using Encorafenib-Based Therapy.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 11, 2025
Evaluating third-line therapies in refractory metastatic colorectal cancer: a systematic review and network meta-analysis.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: May 09, 2025
Pharmacologic features, clinical applications, and drug safety evaluation of futibatinib in the treatment of biliary tract cancer (BTC).
Journal: Expert opinion on drug safety
Published: May 01, 2025
CLO25-095: Baseline Genomic Alterations as Predictors of Response to Anti-HER2 Therapy in HER2-Amplified Advanced Colorectal Cancer (aCRC).
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
Targeting RAS in gastrointestinal malignancies.
Journal: Clinical advances in hematology & oncology : H&O
Published: March 28, 2025
Tucatinib in the treatment of HER2-overexpressing gastrointestinal cancers: current insights and future prospects.
Journal: Expert opinion on investigational drugs
Published: February 28, 2025
Last Updated: 09/26/2026